Pharma Tips

Sanofi to invest Rs 460 crore to make insulin in India

By: Pharma News | Views: 1982 | Date: 01-Feb-2015

French pharma major Sanofi is investing Rs 460 crore to set up a new insulin facility in Hyderabad and augment its capacity to produce Insuman, its human insulin product. The new facility will have the capacity to manufacture up to 60 million cartridges a year and will enable Shantha Biotechnics, the wholly owned subsidiary of Sanofi in India, to cater to emerging markets, including India.

Sanofi to invest Rs 460 crore to make insulin in India

French pharma major Sanofi is investing Rs 460 crore to set up a new insulin facility in Hyderabad and augment its capacity to produce Insuman, its human insulin product. The new facility will have the capacity to manufacture up to 60 million cartridges a year and will enable Shantha Biotechnics, the wholly owned subsidiary of Sanofi in India, to cater to emerging markets, including India.

Sanofi

Located in Muppireddipalli on the outskirts of Hyderabad, it will be Sanofi's second plant apart from the one in Frankfurt, Germany. Telangana Chief Minister K Chandrasekhar Rao laid the foundation stone for the facility on January 29.

According to Harish Iyer, CEO, Shantha Biotechnics, the construction of the 13,500 sq m building will begin immediately. "It will be operational by 2019," he said. The new facility, Iyer said, is being set up under technology transfer within Sanofi. It will enable Shantha Biotechnics to make insulin in cartridge format for the first time. The insulin formulation will be made in the new facility but the bulk (powder) to make the product will continue to be imported from Germany.

Shantha Biotechnics was acquired by Sanofi in 2009. It was a company founded by KI Varaprasad Reddy, who is currently its non-executive chairman. A press release put out by Shantha Biotechnics says that while Sanofi's Frankfurt facility will continue to manufacture Insuman, the new facility will address local demand. In the long run, it could even emerge as Sanofi's injectables' hub for emerging market.

Shailesh Ayyangar, Managing Director, India and Vice-President, South Asia, Sanofi, says in the company release: "By setting up a manufacturing site at Shantha Biotechnics for our diabetes product Insuman, Sanofi is a front-runner in its endeavour of addressing the growing epidemic of diabetes in India. Furthermore, the technology transfer and a successful collaborative effort within the Sanofi Group underline our commitment to investing and 'making in India'. We look forward to the successful completion of the Insuman site construction, so that many more diabetic patients in India can have easier access to better disease management and quality of life."

Previous Page Next Page

People Searching On This Page:
  • investment advice on sanofi india
  • sanofi aventis
  • saniffi

Related Pages


Indian Cabinet approve $750 mn investment by Mylan in India

Indian Cabinet approve $750 mn investment by Mylan in India

News | Pharma Companies
Date:
26-Nov-2015  Views: 14538

"The union cabinet, chaired by Prime Minister Narendra Modi, has approved $750-million FDI in Mylan Laboratories Ltd by Mylan Group through equity sha ...
Modi’s ‘Made in India’ thrust to fuel growth prospects for the Indian Pharma (API) manufacturers

Modi’s ‘Made in India’ thrust to fuel growth prospects for the Indian Pharma (API) manufacturers

News
Date:
29-Sep-2014  Views: 3280

Union government’s ‘Made in India’ emphasis could notch up the growth prospects for the Indian active pharmaceutical ingredient (API) manufacturers. I ...
List of Pharmaceuitical Bottles Suppliers in India

List of Pharmaceuitical Bottles Suppliers in India

Articles | Pharma Suppliers
Date:
02-Dec-2013  Views: 2531

Pharmaceuitical Bottles along with their profiles and contact information. Global buyers looking for genuine manufacturers, suppliers, exporters and t ...
List of Pharmaceutical HDPE Bottle Suppliers in India

List of Pharmaceutical HDPE Bottle Suppliers in India

Articles | Pharma Suppliers
Date:
02-Dec-2013  Views: 5296

High density polyethylene (HDPE) is commonly used for manufacturing of plastic bottles. It is less expensive as compared to other materials and also p ...
Walk in recritement of RSM, ASM and MRs at Overseas Healthcare

Walk in recritement of RSM, ASM and MRs at Overseas Healthcare

Jobs
Date:
12-Jul-2010  Views: 1975

Candidate should be science/pharmacy graduate with relevent experience. Freshers with good communication skills may also apply. ...
Post Your Comments (No Login Require)
Name : (required)
Email : (required)
Website :

Comment : (required)

42  + 4 =     
Comments
People Searched About:
Investment Advice On Sanofi India   |   Sanofi Aventis   |   Saniffi   |  
Google : 416 times | Yahoo : 14 times | Bing : 21 times |